Dr. Jerry L Pruitt, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 245 11th Ave Ne, Hickory, NC 28601 Phone: 828-328-3500 Fax: 828-328-8777 |
Dr. Bethany Bergamo, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1927 3rd Avenue Ln Se, Hickory, NC 28602 Phone: 828-328-3500 Fax: 828-328-8777 |
Dr. George Dimitri Magel, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 315 19th St Se, Hickory, NC 28602 Phone: 828-325-9849 Fax: 828-325-9879 |
Charles S Johnson, M.D. Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 315 19th St Se, Hickory, NC 28602 Phone: 828-325-9849 Fax: 828-325-9879 |
Jake Everett Turrentine, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1899 Tate Blvd Se Ste 2110, Hickory, NC 28602 Phone: 828-328-4449 |
Dr. Karen Trygg Wold, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1985 Tate Blvd Se, Hickory, NC 28602 Phone: 828-328-4449 Fax: 828-328-4809 |
Dori L Hunt, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1927 3rd Avenue Ln Se, Hickory, NC 28602 Phone: 828-328-3500 Fax: 828-328-8777 |
Dr. Charles Nathan Reed, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 1870 N Center St, Hickory, NC 28601 Phone: 828-322-7546 Fax: 828-322-9927 |
News Archive
Critics are missing the larger point. Why should the Department of Health and Human Services (HHS) decree that any of us must pay for "insurance" that covers contraceptives? ... Insurance is a bad idea for small, regular and predictable expenses. There are good reasons that your car insurance company doesn't add $100 per year to your premium and then cover oil changes, and that your health insurance doesn't charge $50 more per year and cover toothpaste.
"A new study suggests that at least one surgical procedure, caesarean delivery, is a highly effective way of improving health at a reasonable cost in developing countries," VOA News reports (Chimes, 4/27).
Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. To address this drawback, pharmaceutical companies have established a robust pipeline that currently has about 52 drugs in development. While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted drugs is on the rise.
A team of researchers at Washington State University has received a three-year, $895,558 grant from the U.S. Department of Defense's Office of Naval Research to study the effects of fatigue on attention, decision making and their underlying biology.
› Verified 4 days ago